Fibrinolysin and Desoxyribonuclease

What is Fibrinolysin and Desoxyribonuclease?

Fibrinolysin and Desoxyribonuclease is a powerful enzymatic combination used primarily in medicine for its ability to break down necrotic tissue and promote wound healing. This preparation typically combines two key enzymes: Fibrinolysin, a proteolytic enzyme that targets fibrin, and Desoxyribonuclease (also known as deoxyribonuclease or DNAse), an enzyme that hydrolyzes deoxyribonucleic acid (DNA). Together, these enzymes work synergistically to clean wounds by removing dead tissue, pus, and other debris that can impede the natural healing process.

Originating often from bovine sources, this enzymatic mixture is commonly formulated into topical preparations such as ointments or gels, making it suitable for direct application to affected areas. Its primary role is to facilitate enzymatic debridement, a non-surgical method of removing dead tissue, which is crucial for preventing infection and encouraging the growth of healthy new tissue. This combination has been a staple in wound care for decades, valued for its targeted action and efficacy.

How Does it Work?

The effectiveness of Fibrinolysin and Desoxyribonuclease stems from the distinct but complementary actions of its two components:

• Fibrinolysin: This enzyme belongs to a class of proteolytic enzymes, meaning it breaks down proteins. Specifically, Fibrinolysin targets fibrin, a protein that is a key component of blood clots and the extracellular matrix found in necrotic tissue. By dissolving fibrin, Fibrinolysin helps to liquefy slough and eschar, making it easier for the body to remove these obstructions. This process is known as fibrinolysis.
• Desoxyribonuclease (DNAse): Necrotic tissue and pus often contain significant amounts of DNA released from dead cells. This DNA can contribute to the viscosity of exudates and form a barrier that hinders healing. Desoxyribonuclease acts by hydrolyzing DNA into smaller fragments, thereby reducing the viscosity of pus and cellular debris. This action helps to loosen and remove the sticky material from the wound surface, allowing for better access for other healing factors and medications.

When applied topically, these enzymes work together to chemically debride the wound. Fibrinolysin breaks down the fibrin meshwork, while Desoxyribonuclease tackles the DNA component of the cellular debris. This dual action effectively cleans the wound bed, reducing bacterial load, minimizing inflammation, and creating an optimal environment for tissue regeneration and overall wound healing.

Medical Uses

The primary medical application for Fibrinolysin and Desoxyribonuclease is in the management of wounds requiring debridement. Its ability to selectively break down necrotic tissue without harming viable tissue makes it invaluable in several clinical scenarios:

• Chronic Ulcers: Including pressure ulcers (bedsores), venous stasis ulcers, and diabetic foot ulcers, where necrotic tissue and slough can delay healing.
• Burns: To assist in the removal of eschar and dead tissue from second- and third-degree burns, preparing the wound for grafting or natural healing.
• Surgical Wounds: For cleaning and debriding post-surgical wounds that have developed necrotic tissue or excessive exudate.
• Traumatic Wounds: To facilitate the removal of devitalized tissue from injuries caused by trauma.
• Other Conditions: Such as abscesses, fistulas, and other localized infections where pus and necrotic material need to be cleared.

By effectively clearing the wound bed, this enzymatic preparation helps to reduce the risk of infection, decrease inflammation, and promote granulation tissue formation, accelerating the healing process.

Dosage

Fibrinolysin and Desoxyribonuclease is typically available as a topical ointment or gel. The specific dosage and frequency of application depend on the type, size, and severity of the wound, as well as the concentration of the enzymes in the product. It is crucial to follow the instructions provided by a healthcare professional or the product's packaging precisely.

Generally, the affected area is cleansed before application. A thin layer of the ointment or gel is then applied directly to the necrotic tissue once or twice daily. The wound may be covered with a sterile dressing, which should be changed regularly. Treatment usually continues until satisfactory debridement has occurred and healthy granulation tissue begins to form. Over-application is not recommended, and prolonged use without medical supervision should be avoided.

Side Effects

While generally well-tolerated, Fibrinolysin and Desoxyribonuclease can cause side effects, particularly at the application site. Most side effects are mild and transient:

• Common Side Effects:
• Mild irritation, redness, or stinging sensation at the application site.
• Transient pain or discomfort.
• Itching or burning.
• Less Common/Serious Side Effects:
• Allergic reactions (e.g., rash, hives, swelling, severe itching, dizziness, difficulty breathing). These are rare but require immediate medical attention.
• Increased exudate or localized swelling, which may indicate an inflammatory response.

If any severe or persistent side effects occur, or if there are signs of an allergic reaction, discontinue use and consult a healthcare provider immediately. It's also important to monitor the wound for signs of infection, such as increased redness, warmth, pus, or fever, as these are not typically direct side effects of the enzymes themselves.

Drug Interactions

Due to its topical application and localized action, systemic drug interactions with Fibrinolysin and Desoxyribonuclease are rare. However, there are some considerations for local interactions:

• Antiseptics and Heavy Metals: Certain antiseptics containing heavy metals (e.g., iodine, silver nitrate, hydrogen peroxide, mercury-containing compounds) can denature or inactivate proteolytic enzymes. It is generally advised to avoid concurrent use of such agents with Fibrinolysin and Desoxyribonuclease, or to ensure thorough rinsing of the wound before applying the enzyme preparation.
• Other Topical Preparations: Caution should be exercised when using other topical medications on the same wound simultaneously, as they might interfere with the enzyme's activity or cause unforeseen local reactions. Always consult with a healthcare professional before combining topical treatments.

Patients should inform their doctor or pharmacist about all other medications, supplements, and topical products they are using to prevent potential interactions.

FAQ

Is Fibrinolysin and Desoxyribonuclease safe to use?

Yes, when used as directed by a healthcare professional, it is generally considered safe. However, like all medications, it can have side effects, and allergic reactions are possible, though rare.

How long does it take for Fibrinolysin and Desoxyribonuclease to work?

The time it takes to see results varies depending on the size and type of the wound and the amount of necrotic tissue. Some improvement may be noticeable within a few days, but complete debridement can take longer. Consistent application is key.

Can Fibrinolysin and Desoxyribonuclease be used on all types of wounds?

It is primarily indicated for wounds with significant necrotic tissue or fibrin. It should not be used on clean, granulating wounds or wounds where debridement is not necessary. Always consult a healthcare provider for proper wound assessment.

Is Fibrinolysin and Desoxyribonuclease a prescription-only medication?

In many regions, preparations containing these enzymes require a prescription due to their potent action and the need for medical supervision in wound care.

Products containing Fibrinolysin and Desoxyribonuclease are available through trusted online pharmacies. You can browse Fibrinolysin and Desoxyribonuclease-based medications at ShipperVIP or Medicenter.

Summary

Fibrinolysin and Desoxyribonuclease is a valuable enzymatic combination in modern wound care, specifically formulated for the effective debridement of necrotic tissue. By combining the fibrinolytic action of Fibrinolysin with the DNA-hydrolyzing activity of Desoxyribonuclease, this topical preparation efficiently cleans the wound bed, removing dead tissue, pus, and debris that hinder healing. Its primary medical uses include the treatment of chronic ulcers, burns, and surgical wounds requiring the removal of devitalized tissue. While generally safe and effective, it is essential to follow prescribed dosages, be aware of potential side effects like local irritation, and avoid interactions with certain other topical agents. Ultimately, this powerful combination plays a crucial role in preparing wounds for optimal healing and preventing complications.